Cargando…

Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results

OBJECTIVES: Recently, the results of two economic evaluations were published both of which seemingly demonstrate the cost-effectiveness of sofosbuvir-based regimens for the treatment of chronic hepatitis C genotype 1 infection in Germany. Both analyses were sponsored by the manufacturer of sofosbuvi...

Descripción completa

Detalles Bibliográficos
Autor principal: Gandjour, Afschin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531817/
https://www.ncbi.nlm.nih.gov/pubmed/33006987
http://dx.doi.org/10.1371/journal.pone.0236543

Ejemplares similares